NIO Inc
BCBA:NIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NIO Inc
BCBA:NIO
|
CN |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
US |
|
A
|
ACI Worldwide Inc
XBER:TSA
|
US |
|
Nextech Ar Solutions Corp
OTC:NEXCF
|
CA |
|
Prosus NV
OTC:PROSF
|
NL |
|
Virco Mfg Corp
NASDAQ:VIRC
|
US |
|
Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
|
SE |
|
Saudi Industrial Development Company SJSC
SAU:2130
|
SA |
|
Ammo Inc
NASDAQ:POWW
|
US |
|
S
|
Sanofi SA
BMV:SNYN
|
FR |
|
Elica SpA
MIL:ELC
|
IT |
|
L
|
Laurent Perrier SA
OTC:LPRRF
|
FR |
|
T
|
Teads BV
NASDAQ:TEAD
|
NL |
|
J
|
JD Sports Fashion PLC
OTC:JDDSF
|
UK |
|
Amerisafe Inc
NASDAQ:AMSF
|
US |
|
Reliance Worldwide Corporation Ltd
ASX:RWC
|
AU |
|
C
|
Compagnie du Cambodge SA
PAR:CBDG
|
FR |
|
Aurora Cannabis Inc
TSX:ACB
|
CA |
Wall St Price Targets
NIO Price Targets Summary
NIO Inc
According to Wall Street analysts, the average 1-year price target for
NIO is 2 668.43 ARS with a low forecast of 1 481.78 ARS and a high forecast of 3 466.04 ARS.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NIO's stock price target?
Price Target
2 668.43
ARS
According to Wall Street analysts, the average 1-year price target for
NIO is 2 668.43 ARS with a low forecast of 1 481.78 ARS and a high forecast of 3 466.04 ARS.
What is the Revenue forecast for NIO Inc?
Projected CAGR
12%
The compound annual growth rate for Revenue over the next 8 years is 12%.